NEKTAR, created in 2002 (United States), from 6 sister brands and 2214 competing brands. The NEKTAR brand is owned by Nektar Therapeutics, a company listed in New York. NEKTAR belongs to the Biotechnology business sector.

NEKTAR is a brand of Nektar Therapeutics (NKTR) Share price

Share price and profitability of the share Nektar Therapeutics (NEKTAR)

Buy Nektar Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 1.32

Portfolio valuation
Nektar Therapeutics (NEKTAR) over 5 years* USD 0.05

Stock market history Nektar Therapeutics (NEKTAR)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more